⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | LIC MF Healthcare Fund - IDCW - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | LIC MF | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹36.36 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Sudhanshu Asthana | Nikhil Mathur |
| Inception | 28 Feb 2019 | 04 Oct 2023 |
| Returns | ||
| 1Y | 10.07% | 22.64% |
| 3Y | 22.26% | 30.41% |
| 5Y | 12.91% | — |
| Since Inception | 18.20% | 29.15% |
| Risk | ||
| 14.35 | 14.07 | |
| 0.59 | 0.59 | |
| 1.02 | 1.59 | |
| 14.41 | 21.67 | |
| 2.24 | 3.48 | |
| -8.87% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.37% | 1.03% |
| Exit Load | Nil upto 12% of units and 1% for remaining units on or before 90D, Nil after 90D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹200 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
LIC MF61%
HDFC MF61%
39.2%Only 39.2% of holdings by weight are common between LIC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingLIC MFHDFC MF
Divi's Laboratories Ltd.9.07%9.39%
Sun Pharmaceutical Industries Ltd.9.59%8.28%
Apollo Hospitals Enterprise Ltd.5.75%3.69%
Torrent Pharmaceuticals Ltd.6.04%3.65%
Aster DM Quality Care Ltd.4.61%3.56%
Neuland Laboratories Ltd.6.14%3.24%
Max Healthcare Institute Ltd.2.99%3.61%
Global Health Ltd.2.59%2.72%
Glenmark Pharmaceuticals Ltd.2.61%2.09%
Category context: Equity vs Equity. Open the full Screener →